- Report
- August 2022
- 218 Pages
Global
From €1787EUR$2,000USD£1,551GBP
- Report
- May 2023
- 80 Pages
Russia
From €1340EUR$1,500USD£1,163GBP
- Report
- January 2025
- 132 Pages
Global
From €849EUR$950USD£737GBP
- Report
- February 2024
- 132 Pages
Global
From €849EUR$950USD£737GBP
- Report
- April 2025
- 42 Pages
United States
- Report
- April 2025
- 46 Pages
United States
- Report
- July 2024
- 132 Pages
Global
From €849EUR$950USD£737GBP
- Webinar
- October 2021
- 60 Minutes
Global
From €170EUR$190USD£147GBP
- Book
- April 2014
United States
- Training
- 75 Minutes
Global
- Training
- 60 Minutes
Global
- Book
- January 2023
- 992 Pages
- Book
- June 2024
- 496 Pages
- Book
- September 2021
- 576 Pages
- Book
- January 2020
- 592 Pages
- Book
- June 2019
- 496 Pages
- Book
- August 2016
- 522 Pages
Global
- Book
- May 2014
- 872 Pages
- Book
- January 2024
- 496 Pages

The Contract Research Organization (CRO) market within the biotechnology sector is a rapidly growing industry. It provides services to biotechnology companies, such as drug discovery, preclinical and clinical trials, and regulatory affairs. CROs are often used to outsource research and development activities, allowing biotechnology companies to focus on their core competencies. CROs also provide access to specialized expertise and resources, such as specialized laboratory equipment and personnel.
CROs are increasingly being used to reduce costs and speed up the development process. They are also used to reduce the risk associated with drug development, as they can provide access to a wide range of expertise and resources.
Some of the major companies in the CRO market include Parexel, Quintiles, Charles River Laboratories, Covance, and PRA Health Sciences. Show Less Read more